# agentlog3 — Reviewer 1 final round

Date: 2026-07-31  
Role: Reviewer 1 (Agent A lineage)  
Prompt: `REVIEW-PROMPT-final.md`

## Order of work

1. Read prompt end-to-end; did not open Reviewer 2 outputs.
2. Reproduced suite: all `check-*.py` OK; all `--selftest` mutations rejected; `check-completeness.py` 11/11 100% with review pending.
3. Phase 1 was already filed as `artifacts/d9-evidence.blind-reauthor.reviewer1.json` (22 D9 goldens + 10 EVIDENCE counterexamples). Enriched with `phase1Diffs` and `a1D9V15_03`.
4. Phase 2 adversarial + blind re-author on FACT-PLANE, C-2, RESOLVED-INPUTS, VERSIONING, TM.
5. Seal + build-from judgment in `artifacts/final-round.seal-and-build.reviewer1.json`.

## Phase 1 result (shared surfaces)

### D9 (`d9-exit-contract.v1.6.json`)

- Sample: 22 goldens covering cause families.
- **Class:** 0 disagreements (22/22).
- **Axes:** 6 field disagreements on 2 goldens only:
  - `user-interrupt-finite` — I used `cannot-seal-coherent-run` / `not-required`; artifact uses `coherent-terminal-run` / `not-applicable`. **Artifact correct:** interrupted is a coherent terminal class.
  - `analysis-cas-link-failed` — I kept analysis-shaped coverage/verdict; artifact uses N/A + `durability=failed` + `domainCondition=host-fault`. **Artifact correct:** host durability fault, not analysis deficiency.
- No B-D9V15-05-class false golden in sample.

### A1-D9-V15-03

**CONFIRM accept X9.** Requested `interruption=none` would encode a falsehood (graceful stop is a signal). X9 closes the order-dependency order-independently.

### EVIDENCE (`evidence.v1.json`)

- 10/10 independent `mustRejectBy` matches from `what` prose alone.
- Residual (not a reject-map defect): A1-RTV4-02 measure Merkle fold cost — leave open as measurement.

## Phase 2 result (Reviewer 1 surfaces)

| Surface | Blind fixtures | Seal | Blocker |
|---|---|---|---|
| FACT-PLANE | 11/12 match; confidence golden disagrees | **SEAL-WITH-CHANGES** | R1-FP-01 confidence→wrong deficiency |
| C-2 | 18/18 match | **SEAL** | — (runtime confinement remains CONDITIONAL) |
| RESOLVED-INPUTS | 6/6 match | **SEAL-WITH-CHANGES** | R1-RI-01 A1-RI-04 product/CI |
| VERSIONING | 7/7 match | **SEAL-WITH-CHANGES** | R1-VER-01 pivot cost ship-gate |
| TM | (adversarial) | **SEAL-WITH-CHANGES** | R1-TM-01 V5 CAS real deletion |

### Key surface answers

- **F8:** Right. C-1 mechanical form holds.
- **C-2 admission boundary:** request-validation vs attempt-admission correct; D9 load-bearing for identity is correct dependency direction.
- **supervised-implementation-effect:** Real schema class; runtime enforcement is a licence until PROBE-CONTRACT — correctly CONDITIONAL, not defeatist.
- **Locale neutralise:** Right for analysis/rules; presentation UX orthogonal.
- **Detector pivot:** Classification sound; cost unmeasured — do not claim cheap.
- **V5 deletion:** Still unsolved; do not paper-seal R5.
- **Ship gate no QUALIFIED:** Correct posture for claims; allow harness-observed failures for first release docs.

## Completeness instrument

- Stated metric (contract-complete) is not inflated in this run: green checkers + goldens + no open findings per surface.
- **Dangerous adjacent reading:** 100% ≠ sealed ≠ build-complete. Undischarged properties and REOPENED PROBE/R-1 sit beside 11/11. That is honest marking, not victory over the hard half — *if* consumer B reads the undischarged list.

## Nine undischarged / PARTIAL

**Honesty, not defeatism.** Paper discharge was the historical failure mode. Keeping runtime authority, support windows, platform matrix, and “product implements architecture” undischarged is correct.

## Build-from judgment (consumer B)

**Yes — build from with track split.**

Build now: D9, FACT-PLANE (post R1-FP-01), C-2 shape validation, RI PlanId policy, VERSIONING compare skeleton, TM host-policy mitigations.

Parallel/blocked: PROBE-CONTRACT, V5 real deletion, EVIDENCE commitment measurement, support windows product owner, A1-RI-04, platform matrix, QUALIFIED operability gates.

Week-one forks avoided if teams implement the sealed/SEAL-with-changes cores above and do not invent a second termination model or collapse scanners into probes.

## Artifacts written this turn

- `artifacts/d9-evidence.blind-reauthor.reviewer1.json` (enriched)
- `artifacts/fact-plane.v1.review-reviewer1.json`
- `artifacts/c2-plan-stage-schema.v3.review-reviewer1.json`
- `artifacts/resolved-inputs.v2.review-reviewer1.json`
- `artifacts/versioning-policy.v2.review-reviewer1.json`
- `artifacts/threat-model.v3.review-reviewer1.json`
- `artifacts/final-round.seal-and-build.reviewer1.json`
- `agentlog3.md` (this file)

## Did not do

- No writes outside `docs/internal/coop/`.
- No ADRs in `docs/decisions/`.
- Did not seal surfaces I flagged (FACT-PLANE, RI, VERSIONING, TM).
- Did not adjudicate my own prior authored architecture text as seal authority — this pass is second-author where fixtures allow.
- Did not read Reviewer 2 outputs before filing.

## 2026-07-31 — Reviewer 2 final-round review

Phase 1 was filed independently before authored derivations/checkers or Reviewer 1 output were read. D9 and EVIDENCE are both **DO-NOT-SEAL**: findings `R2-D9-01..05` and `R2-EVIDENCE-01..05` are in their review artifacts. I confirmed Agent 3's rejection of `A1-D9-V15-03`; graceful serve stop must retain the observed pre-finalization signal.

Phase 2 verdicts are all **DO-NOT-SEAL**:

- FACT-IDENTITY — `R2-FI-01..06`
- OPERABILITY — `R2-OP-01..07`
- DELIVERY — `R2-DL-01..08`
- R-1 — `R2-R1-01..07` (suite assignment was not blind and is labelled accordingly)
- TM — `R2-TM-01..08`; the user-protection center is correct, but V10 and the gate/schema claims are not

Overall: **not complete enough for consumer B to build from as a frozen architecture** (`R2-FINAL-01..03`). All twelve primary checkers and all 110 declared mutation self-tests pass, yet completeness still reports 11/11 after these seven reviews filed 46 open findings; that score does not observe review artifacts.

Artifacts: `artifacts/final-round.seal-and-build.review-reviewer2.json` and the seven `*.review-reviewer2.json` files it indexes. No ADRs, no writes outside `docs/internal/coop/`, no seals, and no claim-register status changes.
